Literature DB >> 8375401

Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine.

A Schrattenholz1, J Godovac-Zimmermann, H J Schäfer, E X Albuquerque, A Maelicke.   

Abstract

The plant alkaloid physostigmine, an established anti-cholinesterase agent of the carbamate type, has recently been shown to bind to the nicotinic acetylcholine receptor from Torpedo marmorata electrocytes [Okonjo, K. O., Kuhlmann, J. & Maelicke, A. (1991) Eur. J. Biochem. 200, 671-677]. Pharmacological studies of physostigmine-induced ion flux into nicotinic-acetylcholine-receptor-rich membrane vesicles, indicated distinct binding sites for physostigmine and acetylcholine. As shown in this study by photoaffinity labeling with [phenyl-(n)-3H](-)physostigmine, the physostigmine-binding site is located within the same subunit (alpha polypeptide) of the receptor as the acetylcholine-binding site. Using a variety of proteolytic cleavage conditions for the purified alpha polypeptide, several [3H]physostigmine-labeled peptides were isolated and sequenced. From the radioactivity released in the course of the Edman degradations of the labeled peptides, it was found that the label was associated in all cases with Lys125. These results identify a novel ligand-binding site for the Torpedo nicotinic acetylcholine receptor that is different in location from binding sites identified previously for acetylcholine, its established agonists and antagonists, and direct channel blockers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375401     DOI: 10.1111/j.1432-1033.1993.tb18187.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the "blind docking" approach.

Authors:  Bogdan Iorga; Denyse Herlem; Elvina Barré; Catherine Guillou
Journal:  J Mol Model       Date:  2005-12-22       Impact factor: 1.810

2.  Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.

Authors:  Gareth T Young; Ruud Zwart; Alison S Walker; Emanuele Sher; Neil S Millar
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-12       Impact factor: 11.205

3.  Photolabeling reveals the proximity of the alpha-neurotoxin binding site to the M2 helix of the ion channel in the nicotinic acetylcholine receptor.

Authors:  J Machold; Y Utkin; D Kirsch; R Kaufmann; V Tsetlin; F Hucho
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

4.  The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors.

Authors:  Xiaochun Jin; Megan M McCollum; Allison L Germann; Gustav Akk; Joe Henry Steinbach
Journal:  Mol Pharmacol       Date:  2016-11-28       Impact factor: 4.436

Review 5.  Photoaffinity labeling of nicotinic receptors: diversity of drug binding sites!

Authors:  Ayman K Hamouda; Selwyn S Jayakar; David C Chiara; Jonathan B Cohen
Journal:  J Mol Neurosci       Date:  2013-10-26       Impact factor: 3.444

Review 6.  Galantamine: a review of its use in Alzheimer's disease.

Authors:  L J Scott; K L Goa
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

7.  Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.

Authors:  Scott B Hansen; Palmer Taylor
Journal:  J Mol Biol       Date:  2007-03-31       Impact factor: 5.469

8.  A structural model of agonist binding to the alpha3beta4 neuronal nicotinic receptor.

Authors:  Valeria Costa; Andrea Nistri; Andrea Cavalli; Paolo Carloni
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

9.  Identification of binding sites in the nicotinic acetylcholine receptor for TDBzl-etomidate, a photoreactive positive allosteric effector.

Authors:  Selvanayagam Nirthanan; Galo Garcia; David C Chiara; S Shaukat Husain; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

10.  Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies.

Authors:  Julius Militante; Bei-Wen Ma; Gustav Akk; Joe Henry Steinbach
Journal:  Mol Pharmacol       Date:  2008-06-03       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.